Jenburkt Pharmaceuticals Limited
NSE: JENBURPH | Information Technology
Market Fundamentals
Stock Intelligence & News
Jenburkt Pharmaceuticals Ltd (524731)
Newspaper Publication for standalone Unaudited Financial Results for the quarter ended on 30th June, 2026.
Read Full Analysis →Jenburkt Pharmaceuticals Ltd (524731)
Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, we are enclosing herewith clippings of the Newspaper publication for Notice of the 41st AGM of the Company.
Read Full Analysis →Jenburkt Pharmaceuticals Ltd (524731)
Submission of the Annual Report for the FY 2025-26, containing Audited Standalone Financial Statements, Auditors Report and Directors Report and the Notice convening 41st Annual General Meeting of the Company.
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Jenburkt Pharmaceuticals Ltd (524731)
AS ON DATE : 03-Aug-2026
Read Full Analysis →Get instant alerts when JENBURPH breaks news
Join investors who track Jenburkt Pharmaceuticals Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for JENBURPH?
JENBURPH is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Jenburkt Pharmaceuticals Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding JENBURPH to your custom watchlist.